The electronic signature market is relatively small but growing due to the convenience advantage it adds to all sides of an agreement.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA05 Oct 2025, 20:45 UTC
AI-generated source summary
The video provides a fundamental analysis of DocuSign (DOCU) stock. The analyst discusses the recent pullback in the stock price, attributing it to competition from DocGPT and insider selling. He mentions that his discounted cash flow valuation model estimates an intrinsic value of $128.31 per share, while the current market price is $69.73. The analyst mentions margin of safety of 5 to 10%. Despite risks of the electronic signature sector, he continues to rate DocuSign as a buy, setting a target of at least $85, and a fail bound close to $62, DOCU's 52 week low.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.